National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

transferrin receptor-targeted liposomal p53 cDNA
A cationic liposomal, tumor-targeting p53 (TP53) gene delivery system with potential anti-tumor activity. Transferrin receptor-targeted liposomal p53 cDNA contains plasmid DNA encoding the tumor suppressor protein p53 packaged in membrane-like liposome capsules that are complexed with anti-transferrin receptor single-chain antibody (TfRscFv). Upon systemic administration, the anti-TfRscFv selectively binds to tumor cells expressing transferrin receptors. The p53 plasmid is delivered into the nucleus and as a result, p53 protein is produced in tumor cells that have altered p53 function. This results in the restoration of normal cell growth control mechanisms as well as normal response mechanisms to DNA damage. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:SGT-53



Previous:TPI 287, trabectedin, tranexamic acid, transdermal estrogen, transferrin receptor-targeted anti-RRM2 siRNA CALAA-01
Next:transferrin-CRM107, transgenic lymphocyte immunization vaccine, TransMID, trastuzumab, Trasylol

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov